5-(4-([1,1'-Biphenyl]-2-yl)piperazin-1-yl)pyrimidine-2,4-diamine

ID: ALA4544467

Chembl Id: CHEMBL4544467

PubChem CID: 152598220

Max Phase: Preclinical

Molecular Formula: C20H22N6

Molecular Weight: 346.44

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1ncc(N2CCN(c3ccccc3-c3ccccc3)CC2)c(N)n1

Standard InChI:  InChI=1S/C20H22N6/c21-19-18(14-23-20(22)24-19)26-12-10-25(11-13-26)17-9-5-4-8-16(17)15-6-2-1-3-7-15/h1-9,14H,10-13H2,(H4,21,22,23,24)

Standard InChI Key:  YWYMUWNXZFMLTG-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4544467

    ---

Associated Targets(Human)

DHFR Tclin Dihydrofolate reductase (3072 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Dihydrofolate reductase (1637 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 346.44Molecular Weight (Monoisotopic): 346.1906AlogP: 2.63#Rotatable Bonds: 3
Polar Surface Area: 84.30Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.50CX LogP: 3.16CX LogD: 2.82
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.76Np Likeness Score: -0.55

References

1. Hopper AT, Brockman A, Wise A, Gould J, Barks J, Radke JB, Sibley LD, Zou Y, Thomas S..  (2019)  Discovery of Selective Toxoplasma gondii Dihydrofolate Reductase Inhibitors for the Treatment of Toxoplasmosis.,  62  (3): [PMID:30624926] [10.1021/acs.jmedchem.8b01754]

Source